Before considering the popular new buttock enhancing procedure, the Brazilian Butt Lift, there are several questions and answers you should ask.
Following the death of beauty queen Solange Magnano, much concern has been raised about the safety of plastic surgery. While there is no 'no risk' procedure, patients must do their due diligence in researching and choosing a physician for the lowest risk possible.
As December ends, we look back on this month fondly and look forward to what 2010 will bring. Happy New Year from American Health and Beauty!
Interim results of a five year study on Artefill indicate that patients are, for the most part, satisfied with their treatment outcome and very few adverse events have been reported.
Following an internationally publicized death after the use of the injectable PMMA, the Physicians Coalition for Injectable Safety urges caution when seeking out the injection of fillers.
After undergoing a cosmetic procedure, former model and 1994's Miss Argentina Solange Magnano died due to pulmonary embolism.
Artes Medical Announces Completion of Enrollment and Treatment in ArteFill Skin Test Study
Ohio Woman Undergoes Transformation Into Runway-Worthy Modern Mom
ArteFill, the first and only FDA-approved non-resorbable injectable dermal filler, provides patients and doctors with a long-lasting solution for the correction of nasolabial folds, or "smile line" wrinkles.
Through this agreement, Artes Medical’s dedicated sales force will market and sell Elevess, the first FDA-approved HA dermal filler for the temporary correction of facial wrinkles that is formulated with an anesthetic for patient comfort, as well as the company’s flagship product, ArteFill, the first and only FDA-approved non-resorbable wrinkle filler for long-lasting correction of smile line wrinkles
Artes Medical, Inc. (Nasdaq:ARTE), maker of the long-lasting dermal filler ArteFill®, is celebrating women’s changing lives with the ArteFill Face Forward Makeover Contest. Women age 35 and over are invited to submit personal stories about a current or upcoming time of personal change. Four winners, selected by a panel of judges, will be honored with makeovers worth approximately $10,000
This newly published study evaluated five different PMMA products available over the past several years in the U.S. (one product), Europe (one product), Brazil (two products) and Canada (one product) for PMMA microsphere size and morphology using Scanning Electron Microscope (SEM) techniques. Each of the five products was evaluated with respect to PMMA microsphere size, homogeneity and surface characteristics. Results from the comparison show marked differences with respect to PMMA microsphere size and morphology. Products obtained from various markets outside the U.S. over time contained variable PMMA particle sizes with shape and surface irregularities, whereas the U.S. product, ArteFill, demonstrated round, smooth, uniformly sized particles.
Feedback from both physicians and patients to date has been very positive, with high levels of interest from consumers to participate in the study.
In addition to presentations on ArteFill’s safety, long-term efficacy, and differences among various dermal filler products, leading plastic surgeons had the opportunity to observe ArteFill in action. Dr. Cohen provided a live patient demonstration with ArteFill injections during “The Importance of Non-Surgical Options in Your Practice” session, showcasing ArteFill’s ease of injection, immediate correction and minimal downtime.
Artes Medical reported that dermatologists, plastic surgeons and cosmetic surgeons are actively integrating ArteFill into their practices and estimates that over 7,000 patients have been treated with the enduring solution, ArteFill, since the product launch in February 2007.
Artes Medical, Inc. (Nasdaq:ARTE) a medical technology company whose product ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today reported the launch of its new consumer-oriented website, ArteFill.com.
Mark G. Rubin, MD from the University of California in San Diego presented data from a 5-year study on the product ArteFill during the American Academy of Dermatology 66th Annual Meeting
ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or "smile line" wrinkles
ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds
Results from the study, led by Steven R. Cohen, MD, Clinical Professor, Division of Plastic Surgery, University of California, San Diego School of Medicine, showcase the safety and aesthetic outcomes over a five-year period in patients treated with ArteFill for nasolabial fold wrinkles.